Blood test could guide anal cancer treatment, reducing side effects
Disease control
Recruiting now
This study tests whether a blood test (ctDNA) can help doctors customize the dose of chemoradiation for people with anal cancer. Depending on how the tumor responds, some patients may get a lower radiation dose to reduce side effects, while others may get a higher dose or an adde…
Phase: PHASE2 • Sponsor: Jennifer Dorth • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC